Toxicity of nanomaterials S Sharifi, S Behzadi, S Laurent, ML Forrest, P Stroeve, M Mahmoudi Chemical Society Reviews 41 (6), 2323-2343, 2012 | 1611 | 2012 |
Effects of nanomaterial physicochemical properties on in vivo toxicity KL Aillon, Y Xie, N El-Gendy, CJ Berkland, ML Forrest Advanced drug delivery reviews 61 (6), 457-466, 2009 | 981 | 2009 |
A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery ML Forrest, JT Koerber, DW Pack Bioconjugate chemistry 14 (5), 934-940, 2003 | 536 | 2003 |
Clinical toxicities of nanocarrier systems KR Vega-Villa, JK Takemoto, JA Yáñez, CM Remsberg, ML Forrest, ... Advanced drug delivery reviews 60 (8), 929-938, 2008 | 410 | 2008 |
Partial Acetylation of Polyethylenimine Enhances In Vitro Gene Delivery ML Forrest, GE Meister, JT Koerber, DW Pack Pharmaceutical research 21, 365-371, 2004 | 309 | 2004 |
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles S Cai, Q Yang, TR Bagby, ML Forrest Advanced drug delivery reviews 63 (10-11), 901-908, 2011 | 277 | 2011 |
Flip-flop pharmacokinetics–delivering a reversal of disposition: challenges and opportunities during drug development JA Yáñez, CM Remsberg, CL Sayre, ML Forrest, NM Davies Therapeutic delivery 2 (5), 643-672, 2011 | 268 | 2011 |
In vitro release of the mTOR inhibitor rapamycin from poly (ethylene glycol)-b-poly (ε-caprolactone) micelles ML Forrest, CY Won, AW Malick, GS Kwon Journal of Controlled Release 110 (2), 370-377, 2006 | 224 | 2006 |
Physical non-viral gene delivery methods for tissue engineering AJ Mellott, ML Forrest, MS Detamore Annals of biomedical engineering 41, 446-468, 2013 | 219 | 2013 |
Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies Y Xie, TR Bagby, MS Cohen, ML Forrest Expert opinion on drug delivery 6 (8), 785-792, 2009 | 213 | 2009 |
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery DA Rao, ML Forrest, AWG Alani, GS Kwon, JR Robinson Journal of pharmaceutical sciences 99 (4), 2018-2031, 2010 | 198 | 2010 |
Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer S Cai, S Thati, TR Bagby, HM Diab, NM Davies, MS Cohen, ML Forrest Journal of Controlled Release 146 (2), 212-218, 2010 | 195 | 2010 |
On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design ML Forrest, DW Pack Molecular therapy 6 (1), 57-66, 2002 | 185 | 2002 |
Amphiphilic block copolymer micelles for nanoscale drug delivery GS Kwon, ML Forrest Drug development research 67 (1), 15-22, 2006 | 166 | 2006 |
Intralymphatic chemotherapy using a hyaluronan–cisplatin conjugate S Cai, Y Xie, TR Bagby, MS Cohen, ML Forrest Journal of Surgical Research 147 (2), 247-252, 2008 | 163 | 2008 |
Cyclodextrin–polyethylenimine conjugates for targeted in vitro gene delivery ML Forrest, N Gabrielson, DW Pack Biotechnology and bioengineering 89 (4), 416-423, 2005 | 146 | 2005 |
Paclitaxel Prodrugs with Sustained Release and High Solubility in Poly(ethylene glycol)-b-poly(ε-caprolactone) Micelle Nanocarriers: Pharmacokinetic Disposition … ML Forrest, JA Yáñez, CM Remsberg, Y Ohgami, GS Kwon, NM Davies Pharmaceutical research 25, 194-206, 2008 | 141 | 2008 |
Poly (aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery MP Xiong, ML Forrest, G Ton, A Zhao, NM Davies, GS Kwon Biomaterials 28 (32), 4889-4900, 2007 | 124 | 2007 |
Pulmonary delivery of cisplatin–hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer Y Xie, KL Aillon, S Cai, JM Christian, NM Davies, CJ Berkland, ML Forrest International journal of pharmaceutics 392 (1-2), 156-163, 2010 | 115 | 2010 |
Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships C Louizos, JA Yáñez, ML Forrest, NM Davies Journal of pharmacy & pharmaceutical sciences 17 (1), 34-91, 2014 | 108 | 2014 |